Sotera Health Company's Chairman and CEO, Michael B. Petras, Jr., announced preliminary full-year 2024 revenue expectations during his presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025. The company expects full-year revenues to be approximately $1.1 billion.
This preliminary figure represents a growth of nearly 5% versus 2023, and more than 5% growth on a constant currency basis. Mr. Petras highlighted this growth as a testament to the resiliency of Sotera Health's business model, which enables it to serve customers effectively across various market environments.
The company anticipates reporting its full 2024 financial results and initial 2025 outlook on February 27, 2025. This early disclosure provides investors with an initial indication of the company's annual performance ahead of the official earnings release.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.